GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (NYSE:ABBV) » Definitions » Dividends per Share

AbbVie (AbbVie) Dividends per Share

: $5.92 (TTM As of Dec. 2023)
View and export this data going back to 2012. Start your Free Trial

AbbVie's dividends per share for the three months ended in Dec. 2023 was $1.48. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.92. Its Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.53. As of today, AbbVie's Dividend Yield % is 3.77%.

During the past 12 months, AbbVie's average Dividends Per Share Growth Rate was 5.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of AbbVie was 23.40% per year. The lowest was 7.80% per year. And the median was 14.30% per year.

For more information regarding to dividend, please check our Dividend Page.


AbbVie Dividends per Share Historical Data

The historical data trend for AbbVie's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.28 4.72 5.20 5.64 5.92

AbbVie Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividends per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.48 1.48 1.48 1.48

Competitive Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where AbbVie's Dividend Yield % falls into.



AbbVie Dividends per Share Calculation

Dividends paid to per common share.


AbbVie  (NYSE:ABBV) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

AbbVie's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=1.48/ 2.79
=0.53

During the past 13 years, the highest Dividend Payout Ratio of AbbVie was 1.41. The lowest was 0.53. And the median was 0.76.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

AbbVie Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 1.5502024-04-122024-04-152024-05-15Cash DividendquarterlyUSD:USD 1.000000
USD 1.5502024-01-122024-01-162024-02-15Cash DividendquarterlyUSD:USD 1.000000
USD 1.4802023-10-122023-10-132023-11-15Cash DividendquarterlyUSD:USD 1.000000
USD 1.4802023-07-132023-07-142023-08-15Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


AbbVie's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=6.06/162.54
=3.73 %

Current Share Price is $162.54.
AbbVie's Dividends per Share for the trailing twelve months (TTM) ended in Today is $6.06.

During the past 13 years, the highest Dividend Yield of AbbVie was 6.30%. The lowest was 0.85%. And the median was 3.57%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AbbVie Dividends per Share Related Terms

Thank you for viewing the detailed overview of AbbVie's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (AbbVie) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Executives
Nicholas Donoghoe officer: SVP, Enterprise Innovation 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Susan E Quaggin director 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jennifer L. Davis director 1 PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Richard A Gonzalez officer: Chairman of the Board and CEO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Elaine K. Sorg officer: Sr. V.P., U.S. Commercial Ops. 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Perry C Siatis officer: EVP, GC and Secretary 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jeffrey Ryan Stewart officer: SVP, US Commercial Operations 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Kevin K Buckbee officer: SVP, Controller 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Scott T Reents officer: SVP, Chief Financial Officer 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Azita Saleki-gerhardt officer: SVP, Operations 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Carrie C Strom officer: SVP & Pres Global Allerg Aesth 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Roxanne S Austin director 200 N SEPULVEDA BLVD, PO BOX 956 MS ES/001/A102, EL SEGUNDO CA 90245
Timothy J. Richmond officer: EVP, Chief HR Officer 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Michael Severino officer: EVP, R&D and CSO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Henry O Gosebruch officer: Chief Strategy Officer 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064-6092

AbbVie (AbbVie) Headlines